Rosen, highly regarded investor counsel, encourages iovance biotherapeutics, inc. investors to secure counsel before important deadline in securities class action – iova

New york, june 01, 2025 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of iovance biotherapeutics, inc. (nasdaq: iova) between may 9, 2024 and may 8, 2025, both dates inclusive (the “class period”), of the important july 14, 2025 lead plaintiff deadline.
IOVA Ratings Summary
IOVA Quant Ranking